Supplemental Prevention of Sepsis?
- PMID: 40767568
- DOI: 10.1097/CCM.0000000000006823
Supplemental Prevention of Sepsis?
Keywords: biobanking; cohort study; glutamine; immune response; infection; inflammation.
References
-
- Pauling L: The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad Sci U S A. 1971; 68:2678–2681
-
- Angriman F, Muttalib F, Lamontagne F, et al.; LOVIT Investigators: IV vitamin C in adults with sepsis: A Bayesian reanalysis of a randomized controlled trial. Crit Care Med. 2023; 51:e152–e156
-
- Lamontagne F, Masse MH, Menard J, et al.; LOVIT Investigators and the Canadian Critical Care Trials Group: Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. 2022; 386:2387–2398
-
- Sibbritt D, Adams J, Lui CW, et al.: Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older. PLoS One. 2012; 7:e41540
-
- Li Y, Xie M, Men L, et al.: O-GlcNAcylation in immunity and inflammation: An intricate system (Review). Int J Mol Med. 2019; 44:363–374
LinkOut - more resources
Full Text Sources